Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
63.2M
-
Shares change
-
+1.33M
-
Total reported value, excl. options
-
$5.87B
-
Value change
-
+$102M
-
Put/Call ratio
-
0.47
-
Number of buys
-
77
-
Number of sells
-
-84
-
Price
-
$92.96
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2022
208 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q2 2022.
Ascendis Pharma A/S - ADR (ASND) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.2M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.57M shares), Artisan Partners Limited Partnership (7.47M shares), FMR LLC (5.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.17M shares), BAKER BROS. ADVISORS LP (4.85M shares), JANUS HENDERSON GROUP PLC (3.86M shares), WELLINGTON MANAGEMENT GROUP LLP (3.55M shares), GOLDMAN SACHS GROUP INC (3.32M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.79M shares), and Avoro Capital Advisors LLC (2.28M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.